Denali Therapeutics Inc Stock Ownership - Who owns Denali Therapeutics?

Insider buying vs selling

Have Denali Therapeutics Inc insiders been buying or selling?
Vicki L. SatoDirector2023-09-1540$24.35
Vicki L. SatoDirector2023-09-151,626$23.60
Carole HoChief Medical Officer2023-08-232,522$23.22
Alexander O. SchuthCOFO and Secretary2023-08-232,522$23.17
Steve E. KrognesDirector2023-08-211,419$22.60
Alexander O. SchuthCOFO and Secretary2023-08-212,478$22.59
Ryan J. WattsPresident and CEO2023-08-212,309$22.59
Carole HoChief Medical Officer2023-08-212,478$22.60
Vicki L. SatoDirector2023-08-151,666$24.30
Carole HoChief Medical Officer2023-08-142,768$23.79

1 of 7

DNLI insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DNLI insiders and whales buy or sell their stock.

DNLI Shareholders

What type of owners hold Denali Therapeutics Inc stock?
Robert Nelsen15.10%20,749,930$434.92MInsider
Baillie Gifford Co10.80%14,843,770$311.13MInstitution
Biogen Inc9.69%13,310,243$278.98MInsider
Arch Venture Fund Viii LP7.76%10,668,749$223.62MInsider
Vanguard Group Inc7.45%10,242,983$214.69MInstitution
Blackrock Inc7.35%10,106,275$211.83MInstitution
Douglas K. Bratton7.34%10,084,938$211.38MInsider
Fmr LLC7.12%9,779,988$204.99MInsider
Flagship Ventures Fund V LP6.49%8,918,749$186.94MInsider
Wellington Management Group LLP5.12%7,038,176$147.52MInstitution

1 of 3

DNLI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DNLI55.73%44.27%Net SellingNet Selling
CYTK87.80%12.20%Net SellingNet Selling
AKRO66.26%33.74%Net SellingNet Buying
NTLA67.03%32.97%Net SellingNet Selling
CORT29.64%70.36%Net BuyingNet Selling

Denali Therapeutics Stock Ownership FAQ

Who owns Denali Therapeutics?

Denali Therapeutics (NASDAQ: DNLI) is owned by 78.03% institutional shareholders, 61.98% Denali Therapeutics insiders, and 0.00% retail investors. Robert Nelsen is the largest individual Denali Therapeutics shareholder, owning 20.75M shares representing 15.10% of the company. Robert Nelsen's Denali Therapeutics shares are currently valued at $428.07M.

If you're new to stock investing, here's how to buy Denali Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.